Skip to main content
梓橦宫 logo

梓橦宫 — Investor Relations & Filings

Ticker · 920566 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 625 across all filing types
Latest filing 2022-12-13 Legal Proceedings Report
Country CN China
Listing Beijing Stock Exchange 920566

About 梓橦宫

http://www.zitonggong.com/

Zitonggong specializes in the research, development, and production of specialized therapeutic agents. Established with a heritage dating back to 1780, the company holds a recognized heritage brand designation. Its primary product portfolio centers on neurological and cerebrovascular health, featuring Oxiracetam in various dosage forms for treating cognitive dysfunction and brain injuries. The company also develops treatments for digestive health, including Compound Aloe Capsules, and produces artificial Oriental Bezoar. Operations are centered on integrating traditional medicinal knowledge with modern chemical synthesis and manufacturing standards. The company maintains a focus on clinical efficacy and technological advancement in the fields of neurology and gastroenterology.

Recent filings

Filing Released Lang Actions
关于四川证监局对公司采取行政监管措施决定的整改报告（更正后）
Legal Proceedings Report Classification · 95% confidence The document is a detailed corrective action report issued by Sichuan Zitonggong Pharmaceutical Co., Ltd. in response to administrative regulatory measures taken by the Sichuan Securities Regulatory Bureau. It includes a comprehensive description of the regulatory findings, the company's internal control deficiencies, employee supervision issues, and the specific corrective measures and ongoing improvement plans. The document is not a financial report like an annual or interim report, nor is it a brief announcement or voting result. It is a regulatory compliance and corrective action report related to legal and governance issues following a regulatory inspection. This fits best under the category of Legal Proceedings Report (LTR), as it details regulatory actions and the company's response to them.
2022-12-13 Chinese
关于四川证监局对公司采取行政监管措施决定的整改报告(更正公告)
Regulatory Filings Classification · 95% confidence The document is a correction announcement related to a previously disclosed regulatory report about administrative regulatory measures taken by the Sichuan Securities Regulatory Bureau against the company. It references a prior announcement and provides a corrected version of that announcement. The document is short (570 characters) and primarily serves to correct and clarify a previous filing rather than presenting new financial data or detailed report content. It does not contain financial statements, management discussion, or audit information. Therefore, it fits best as a Regulatory Filing (RNS), which covers miscellaneous regulatory announcements and corrections that do not fit other specific categories.
2022-12-13 Chinese
关于四川证监局对公司采取行政监管措施决定的整改报告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolution passed at the 14th meeting of the 3rd Supervisory Board of Sichuan Zitonggong Pharmaceutical Co., Ltd. It details the meeting's convening, attendance, and the approval of a report related to regulatory administrative measures by the Sichuan Securities Regulatory Bureau. The document is an official meeting resolution announcement rather than a full report or financial statement. It does not contain financial data or detailed management discussion but rather governance-related content about board meeting decisions. Therefore, it fits best under Board/Management Information (MANG), which covers announcements of changes or decisions by company boards or senior management.
2022-12-13 Chinese
第三届董事会第十六次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the 16th meeting of the 3rd Board of Directors of Sichuan Zitonggong Pharmaceutical Co., Ltd. It details the meeting date, attendance, agenda items, and voting results. The content focuses on board meeting decisions, including approval of a regulatory compliance report, and does not contain financial statements or detailed financial performance data. It is not an annual or interim report, earnings release, or audit report. The document is clearly a Board/Management Information announcement about board meeting resolutions and related compliance matters. Therefore, the appropriate classification is MANG (Board/Management Information). The document length is short and it is not merely an announcement of a report publication, but a substantive board meeting resolution notice, supporting high confidence.
2022-12-13 Chinese
关于公司收到四川证监局行政监管措施决定书的公告
Regulatory Filings Classification · 95% confidence The document is an official announcement from a company regarding an administrative regulatory measure decision issued by the Sichuan Securities Regulatory Bureau, part of the China Securities Regulatory Commission. It details the nature of the regulatory action, the alleged violations related to internal control deficiencies and accounting issues, the regulatory basis for the action, and the company's response and remediation plan. The document does not contain financial statements or detailed financial data but is a regulatory announcement about a compliance issue and administrative penalty. It is not an audit report, annual report, or earnings release, but rather a regulatory filing informing the market and investors about the regulatory action and the company's corrective measures. Therefore, the appropriate classification is Regulatory Filings (RNS). The document length is short (1923 characters), consistent with a regulatory announcement rather than a full report.
2022-11-27 Chinese
关于子公司技术中心被认定为市企业技术中心的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (594 characters) regarding the recognition of a subsidiary's technology center as a municipal enterprise technology center. It includes a statement from the board ensuring the accuracy of the announcement and describes the impact on the company. There are no financial statements, no detailed financial data, no regulatory certifications, or voting results. The document is an official announcement about a corporate development related to technology recognition, not a financial report or management change. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Board/Management Information. It is a regulatory announcement about a corporate event. Given the short length and nature, it is best classified as a Regulatory Filing (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2022-11-16 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.